Literature DB >> 19695308

Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells.

Severine Brule1, Véronique Friand, Angela Sutton, Françoise Baleux, Liliane Gattegno, Nathalie Charnaux.   

Abstract

BACKGROUND: In addition to their physiologic effects in inflammation and angiogenesis, chemokines are involved in cancer pathology. The CXC-chemokine stromal cell-derived factor-1 (SDF-1)/CXCL12 mediates its biological activities through activation of G protein-coupled receptor CXCR4 and binds to glycosaminoglycans (GAGs).
METHODS: Using Bio-coat cell migration chambers, specific antagonists, flow cytometry and RNA interference, we evaluate the involvement of heparan sulfate proteoglycans (HSPG) in the SDF-1/CXCL12-induced invasion of human cervix epitheloid carcinoma HeLa cells.
RESULTS: The SDF-1/CXCL12-induced cell invasion is dependent on CXCR4. Furthermore, Protein Kinase C delta (PKC delta) and c-jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) are implicated in this event, but not extracellular signal-regulated kinase (ERK) 1/2. Moreover, the invasion of HeLa cells induced by SDF-1/CXCL12 was dependent on matrix metalloproteinase-9 (MMP-9). The pre-incubation of HeLa cells with heparin or with anti-heparan sulfate antibodies or with beta-d-xyloside inhibited SDF-1/CXCL12-mediated cell invasion. Furthermore, the down-regulation of syndecan-4, a heparan sulfate proteoglycan, decreased SDF-1/CXCL12-mediated HeLa cell invasion. GAGs, probably on syndecan-4, are involved in SDF-1/CXCL12-mediated cell chemotaxis. GENERAL SIGNIFICANCE: These data suggest that targeting the glycosaminoglycan/chemokine interaction could be a new therapeutic approach for carcinomas in which SDF-1/CXCL12 is involved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19695308     DOI: 10.1016/j.bbagen.2009.08.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Novel glycosaminoglycan biosynthetic inhibitors affect tumor-associated angiogenesis.

Authors:  Karthik Raman; Masayuki Ninomiya; Thao Kim Nu Nguyen; Yasuhiro Tsuzuki; Mamoru Koketsu; Balagurunathan Kuberan
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

Review 2.  Syndecans in cartilage breakdown and synovial inflammation.

Authors:  Thomas Pap; Jessica Bertrand
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

3.  CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.

Authors:  Hai-bo Shen; Zheng-qin Gu; Kang Jian; Juan Qi
Journal:  Tumour Biol       Date:  2013-03-23

4.  Oligomannurarate sulfate inhibits CXCL12/SDF-1-mediated proliferation and invasion of human tumor cells in vitro.

Authors:  Wei-wei Wen; Shao Xie; Xian-liang Xin; Mei-yu Geng; Jian Ding; Yi Chen
Journal:  Acta Pharmacol Sin       Date:  2013-10-21       Impact factor: 6.150

Review 5.  Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer.

Authors:  Jessica Oyie Sousa Onyeisi; Carla Cristina Lopes; Martin Götte
Journal:  Biomolecules       Date:  2021-03-26

6.  Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours.

Authors:  Vassiliki T Labropoulou; Spyros S Skandalis; Panagiota Ravazoula; Petros Perimenis; Nikos K Karamanos; Haralabos P Kalofonos; Achilleas D Theocharis
Journal:  Biomed Res Int       Date:  2013-06-15       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.